The U.S. government’s Johnson & Johnson vaccine dose allocation is expected to drop 85% next week, the Centers for Disease Control and Prevention reported.
Only about 785,000 doses of the Johnson & Johnson vaccine are expected to be rolled out in states and other jurisdictions next week, up from five million doses this week.
The drop in supply comes after the company had to throw away 15 million doses of its coronavirus vaccine last month because the batch did not meet quality standards.
The distribution of Pfizer-BioNTech and Moderna vaccine doses will remain stable, with 4.7 million first doses of Pfizer and 3.5 million first doses of Moderna allocated to states.
The drop in doses of J&J has forced at least officials in one state to reorganize some distribution plans. Connecticut recently learned that its planned shipment of 20,000 doses of J&J next week would drop to 6,000 and then 2,000 the following week, halting plans to target vaccinations for students.
Meanwhile, more than a third of Americans have received at least one vaccine, and more than a quarter of American adults are now fully vaccinated, according to data released Thursday as part of the CDC broadcasts. Just under a fifth of all Americans have been fully immunized.
USA TODAY analysis shows that 47% of people in Palau and 45% of people in New Hampshire are at least partially vaccinated. On the other side, there are about 14% of Americans in Micronesia, with Mississippi being the lowest state with less than 27% partially vaccinated.
Also in the news:
►A mass vaccination site in Colorado was closed after 11 people experienced “side effects” including nausea and dizziness after receiving the one-dose Johnson & Johnson vaccine.
► Vermont is preparing to welcome the return of Amtrak passenger rail service and intercity bus services to the state, the Transportation Agency said Thursday.
►The Roland-Garros tennis tournament will be delayed for a week in May due to the coronavirus pandemic, organizers announced Thursday.
►The University of Notre-Dame announced Thursday that it will become the last college to require all students to be fully vaccinated against COVID-19 for the fall semester.
►Filipino authorities are investigating the death of a 28-year-old man forced to do nearly 300 squat drills after officials said he violated local COVID-19 curfew rules last week.
►The State of Florida has taken legal action against the federal government to demand that cruise ships begin to sail.
📈 Today’s numbers: The United States has nearly 31 million confirmed cases of coronavirus and 560,000 deaths, according to data from Johns Hopkins University. Global totals: over 133.7 million cases and 2.89 million deaths. At least 225.2 million doses of the vaccine have been distributed in the United States and 171.4 million have been administered, according to the CDC.
📘 What we read: Post-traumatic growth post-COVID-19 could bring creativity and joy back to your life. But maybe not until 2024. Read the full story.
USA TODAY follows COVID-19 news. Keep refreshing this page for the latest updates. Want more? Sign up for our Coronavirus Watch newsletter for updates to your inbox and join our Facebook group.
A study of three COVID-19 survivors diagnosed with a brain or mental disorder
A massive study conducted during the pandemic estimates that one in three COVID-19 survivors were diagnosed with neurological or psychiatric illness within six months of infection.
The study, published Tuesday in the peer-reviewed journal The Lancet Psychiatry, used more than 230,000 electronic health records of patients with COVID-19, primarily in the United States, examining 14 different brain and health disorders mental.
Thirty-four percent of survivors were diagnosed with at least one of these conditions, with 13% of those people being their first recorded neurological or psychiatric diagnosis. Mental health diagnoses were the most common among patients, with 17% diagnosed with anxiety and 14% with a mood disorder.
Although neurological diagnoses are rarer, they were more common in critically ill patients during COVID-19 infection. For example, 7% of patients admitted to intensive care had a stroke and 2% were diagnosed with dementia.
– Adrianna Rodriguez
If UK is any sign, vaccines could have a blunt impact from the US spring surge
Wednesday’s announcement by the CDC that the highly transmissible variant of the coronavirus first identified in Britain is now the dominant strain in the United States has worrying implications, but recent developments in the United Kingdom offer a glimmer hope.
Researchers at Imperial College London found that COVID-19 infections fell by around 60% in March, with national lockdowns slowing the spread of the virus. People 65 and older were the least likely to be infected because they benefited the most from the vaccination program, which initially focused on the elderly.
The study also found that the relationship between infections and deaths is divergent, “suggesting that infections may have resulted in fewer hospitalizations and deaths since the start of generalized vaccination.”
In the United States, even though infections have increased by 14% in the past two weeks, the rate of hospitalizations has only increased by 5% and reported deaths – which are typically about four weeks behind – are down 31%, according to the New York Times. tracker.
The United States follows only Great Britain among the major countries in the number of vaccine doses given per 100 people, 55-51. In comparison, France is just under 19 years old. The United States has also given at least one vaccine vaccine to 75% of its population aged 65 and over, who are most vulnerable to the virus.
This suggests that the spring surge that many health experts fear will not be as brutal as that of winter, which was capped by a record high of more than 95,000 deaths in January.
“It’s almost a race between getting people vaccinated and this wave that looks set to increase,” Presidential Advisor Dr Anthony Fauci told CNN on Wednesday.
Contribute: The Associated Press
